Potent vasodilation effect of amurensin G is mediated through the phosphorylation of endothelial nitric oxide synthase

Biochemical Pharmacology

Volumn 84, Issue 11, 2012, Pages 1437-1450

  Hien, Tran Thi ^a,b   Oh, Won Keun ^a   Quyen, Bui Thu ^b   Dao, Trong Tuan ^a   Yoon, Jung Hoon ^c   Yun, Sei Young ^d   Kang, Keon Wook ^b  

^a Chosun University   (South Korea)

^b Seoul National University   (South Korea)

^c Wonkwang University   (South Korea)

^d Kwangju Women University   (South Korea)

Author keywords

AMPK; Amurensin G; eNOS; Estrogen receptor; PI3 kinase Akt

Indexed keywords

ADENYLATE KINASE; AMURENSIN G; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE; PLANT EXTRACT; PROTEIN KINASE B; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ADHERENT CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; CYTOTOXICITY TEST; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ESTROGEN RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR RING; VASODILATATION; VITIS; VITIS AMURENSIS;

BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; DIBENZOCYCLOHEPTENES; DNA PRIMERS; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RESORCINOLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASODILATOR AGENTS;

EID: 84868485946     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.09.004     Document Type: Article

References (59)

1. M.E. Widlansky, N. Gokce, J.J. Keaney, and J.A. Vita The clinical implications of endothelial dysfunction J Am Coll Cardiol 42 2003 1149 1160
2. Z. Fatehi-Hassanabad, C.B. Chan, and B.L. Furman Reactive oxygen species and endothelial function in diabetes Eur J Pharmacol 636 2010 8 17
3. S. Moncada, and A. Higgs The l-arginine-nitric oxide pathway N Engl J Med 329 1993 2002 2012
4. L.G. Howes, D. Abbott, and N.E. Straznicky Lipoproteins and cardiovascular reactivity Br J Clin Pharmacol 44 1997 319 324
5. S. Afrose, M.S. Hossain, T. Maki, and H. Tsujii Karaya root saponin exerts a hypocholesterolemic response in rats fed a high-cholesterol diet Nutr Res 29 2009 350 354
6. S. Katsuda, K. Suzuki, N. Koyama, M. Takahashi, M. Miyake, and A. Hazama Safflower seed polyphenols (N-(p-coumaroyl)serotonin and N-feruloylserotonin) ameliorate atherosclerosis and distensibility of the aortic wall in Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits Hypertens Res 32 2009 944 949
7. M. Magnone, S. Bruzzone, L. Guida, G. Damonte, E. Millo, and S. Scarfì Abscisic acid released by human monocytes activates monocytes and vascular smooth muscle cell responses involved in atherogenesis J Biol Chem 284 2009 17808 17818
8. J.F. Savouret, and M. Quesne Resveratrol cancer: a review Biomed Pharmacother 56 2002 84 87
9. W.B. Kannel, and R.C. Ellison Alcohol and coronary heart disease: the evidence for a protective effect Clin Chim Acta 246 1996 59 76
10. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat Rev Drug Discov 5 2006 493 506
11. O. Vang, N. Ahmad, C.A. Baile, J.A. Baur, K. Brown, and A. Csiszar What is new for an old molecule? Systematic review and recommendations on the use of resveratrol PLoS ONE 6 2011 e19881
12. J.M. Smoliga, J.A. Baur, and H.A. Hausenblas Resveratrol and health-a comprehensive review of human clinical trials Mol Nutr Food Res 55 2011 1129 1141
13. H. Ghanim, C.L. Sia, S. Abuaysheh, K. Korzeniewski, P. Patnaik, and A. Marumganti An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol J Clin Endocrinol Metab 95 2010 E1 E8
14. K.S. Huang, M. Lin, and G.F. Cheng Anti-inflammatory tetramers of resveratrol from the roots of Vitis amurensis and the conformations of the seven-membered ring in some oligostilbenes Phytochemistry 58 2001 357 362
15. C.M. Klinge, N.S. Wickramasinghe, M.M. Ivanova, and S.M. Dougherty Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells FASEB J 22 2008 2185 2197
16. D.M. Arrick, H. Sun, K.P. Patel, and W.G. Mayhan Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats Am J Physiol Heart Circ Physiol 301 2011 H696 H703
17. T. Simoncini, E. Rabkin, and J.K. Liao Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-kinase in endothelial cells Arterioscler Thromb Vasc Biol 23 2003 198 203
18. K. Hisamoto, M. Ohmichi, H. Kurachi, J. Hayakawa, Y. Kanda, and Y. Nishio Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells J Biol Chem 276 2001 3459 3467
19. E.A. Bradley, E.C. Eringa, C.D. Stehouwer, I. Korstjens, G.P. van Nieuw Amerongen, and R. Musters Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion Arterioscler Thromb Vasc Biol 30 2010 1137 1142
20. T. Ha do, Q.C. Chen, T.M. Hung, U.J. Youn, T.M. Ngoc, and P.T. Thuong Stilbenes and oligostilbenes from leaf and stem of Vitis amurensis and their cytotoxic activity Arch Pharm Res 32 2009 177 183
21. A. Mutoh, M. Isshiki, and T. Fujita Aldosterone enhances ligand-stimulated nitric oxide production in endothelial cells Hypertens Res 31 2008 1811 1820
22. W. Wang, D. Jiang, Y. Zhu, W. Liu, J. Duan, and S. Dai Relaxing effects of phytoestrogen alpha-zearalanol on rat thoracic aorta rings in vitro Chin J Physiol 52 2009 99 105
23. H. Shioiri, T. Komaru, K. Sato, K. Takahashi, S. Takeda, and H. Kanatsuka Impact of hypercholesterolemia on acidosis-induced coronary microvascular dilation Basic Res Cardiol 98 2003 76 83
24. P.Y. Cheng, Y.M. Lee, M.T. Chung, Y.C. Shih, and M.H. Yen Role of AMP-activated protein kinase in α-lipoic acid-induced vasodilatation in spontaneously hypertensive rats Am J Hypertens 25 2012 152 158
25. 2+ levels and nitric oxide release in human endothelial cells Mol Nutr Food Res 55 2011 1237 1248
26. R. Merla, Y. Ye, Y. Lin, S. Manickavasagam, M.H. Huang, and R.J. Perez-Polo The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation Am J Physiol Heart Circ Physiol 293 2007 H1918 H1928
27. G.H. Perdew, B.D. Hollingshead, B.C. Dinatale, J.L. Morales, M.P. Labrecque, and M.K. Takhar Estrogen receptor expression is required for low-dose resveratrol-mediated repression of aryl hydrocarbon receptor activity J Pharmacol Exp Ther 335 2010 273 283
28. C. Villalonga-Barber, A.K. Meligova, X. Alexi, B.R. Steele, C.E. Kouzinos, and C.G. Screttas New hydroxystilbenoid derivatives endowed with neuroprotective activity and devoid of interference with estrogen and aryl hydrocarbon receptor-mediated transcription Bioorg Med Chem 19 2011 339 351
29. T. Simoncini, A. Hafezi-Moghadam, D.P. Brazil, K. Ley, W.W. Chin, and J.K. Liao Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase Nature 407 2002 538 541
30. J.G. Moggs, and G. Orphanides Estrogen receptors: orchestrators of pleiotropic cellular responses EMBO Rep 2 2001 775 781
31. T.T. Hien, W.K. Oh, P.H. Nguyen, S.J. Oh, M.Y. Lee, and K.W. Kang Nectandrin B activates endothelial nitric-oxide synthase phosphorylation in endothelial cells: role of the AMP-activated protein kinase/estrogen receptor α/phosphatidylinositol 3-kinase/Akt pathway Mol Pharmacol 80 2011 1166 1178
32. K.L. Chambliss, I.S. Yuhanna, R.G. Anderson, M.E. Mendelsohn, and P.W. Shaul ERbeta has nongenomic action in caveolae Mol Endocrinol 16 2002 938 946
33. K.L. Chambliss, I.S. Yuhanna, C. Mineo, P. Liu, Z. German, and T.S. Sherman Estrogen receptor alpha and eNOS are organized into a functional signaling module in caveolae Circ Res 87 2000 E44 E52
34. M.J. Kelly, and E.J. Wagner Estrogen modulation of G-protein-coupled receptors Trends Endocrinol Metab 10 1999 369 374
35. L. Li, M.P. Haynes, and J.R. Bender Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells Proc Natl Acad Sci USA 100 2003 4807 4812
36. M.H. Wyckoff, K.L. Chambliss, C. Mineo, I.S. Yuhanna, M.E. Mendelsohn, and S.M. Mumby Plasma membrane estrogen receptors are coupled to eNOS through Galpha(i) J Biol Chem 276 2001 27071 27076
37. M.P. Haynes, L. Li, D. Sinha, K.S. Russell, K. Hisamoto, and R. Baron Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen J Biol Chem 278 2003 2118 2123
38. M. Zang, S. Xu, K.A. Maitland-Toolan, A. Zuccollo, X. Hou, and B. Jiang Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice Diabetes 55 2006 2180 2191
39. V.A. Morrow, F. Foufelle, J.M. Connell, J.R. Petrie, G.W. Gould, and I.P. Salt Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells J Biol Chem 278 2003 31629 31639
40. M.H. Hsu, U. Savas, J.M. Lasker, Johnson, and E.F. Genistein Resveratrol and 5-aminoimidazole-4-carboxamide-1-{beta}-d-ribofuranoside induce cytochrome P450 4F2 expression through an AMP-activated protein kinase-dependent pathway J Pharmacol Exp Ther 337 2011 125 136
41. S. Chakrabarti, and S.T. Davidge High glucose-induced oxidative stress alters estrogen effects on ERalpha and ERbeta in human endothelial cells: reversal by AMPK activator J Steroid Biochem Mol Biol 117 2009 99 106
42. T.M. D'Eon, N.H. Rogers, Z.S. Stancheva, and A.S. Greenberg Estradiol and the estradiol metabolite, 2-hydroxyestradiol, activate AMP-activated protein kinase in C2C12 myotubes Obesity 16 2008 1284 1288
43. J.N. Wang, Y.J. Chen, Y. Hano, T. Nomura, and R.X. Tan Antioxidant activity of polyphenols from seeds of Vitis amurensis in vitro Acta Pharmacol Sin 21 2000 633 636
44. W.K. Oh, K.B. Cho, T.T. Hien, T.H. Kim, H.S. Kim, and T.T. Dao Amurensin G, a potent natural SIRT1 inhibitor, rescues doxorubicin responsiveness via down-regulation of multidrug resistance 1 Mol Pharmacol 78 2010 855 864
45. S.H. Kim, T.K. Kwon, and T.Y. Shin Antiallergic effects of Vitis amurensis on mast cell-mediated allergy model Exp Biol Med (Maywood) 233 2008 192 199
46. T.R. Räthel, R. Samtleben, A.M. Vollmar, and V.M. Dirsch Activation of endothelial nitric oxide synthase by red wine polyphenols: impact of grape cultivars, growing area and the vinification process J Hypertens 25 2007 541 549
47. D. Fulton, J.P. Gratton, T.J. McCabe, J. Fontana, Y. Fujio, and K. Walsh Regulation of endothelium-derived nitric oxide production by the protein kinase Akt Nature 399 1999 597 601
48. H. Cai, Z. Li, M.E. Davis, W. Kanner, D.G. Harrison, and S.C.J. Dudley Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide Mol Pharmacol 63 2003 325 331
49. R.A. Campbell, P. Bhat-Nakshatri, N.M. Patel, D. Constantinidou, S. Ali, and H. Nakshatri Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance J Biol Chem 276 2001 9817 9824
50. B.D. Gehm, J.M. McAndrews, P.Y. Chien, and J.L. Jameson Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor Proc Natl Acad Sci USA 94 1997 14138 14143
51. H.K. Choi, J.W. Yang, and K.W. Kang Bifunctional effect of resveratrol on the expression of ErbB2 in human breast cancer cell Cancer Lett 242 2006 198 206
52. P.J. Kushner, D.A. Agard, G.L. Greene, T.S. Scanlan, A.K. Shiau, and R.M. Uht Estrogen receptor pathways to AP-1 J Steroid Biochem Mol Biol 74 2007 311 317
53. S.O. Mueller, S. Simon, K. Chae, M. Metzler, and K.S. Korach Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells Toxicol Sci 80 2004 14 25
54. K.H. Kim, and J.R. Bender Membrane-initiated actions of estrogen on the endothelium Mol Cell Endocrinol 308 2009 3 8
55. S. Namkoong, C.K. Kim, Y.L. Cho, J.H. Kim, H. Lee, and K.S. Ha Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling Cell Signal 21 2009 906 915
56. D.G. Hardie AMP-activated protein kinase as a drug target Annu Rev Pharmacol Toxicol 47 2007 185 210
57. J.H. Um, S.J. Park, H. Kang, S. Yang, M. Foretz, and M.W. McBurney AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol Diabetes 59 2010 554 563
58. B. Thors, H. Halldórsson, and G. Thorgeirsson eNOS activation mediated by AMPK after stimulation of endothelial cells with histamine or thrombin is dependent on LKB1 Biochim Biophys Acta 1813 2011 322 331
59. C. Procopio, F. Andreozzi, E. Laratta, A. Cassese, F. Beguinot, and F. Arturi Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5′-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein Endocrinology 150 2009 3584 3593